课题基金 / 基金详情

Fundamental Research on the Development of a New Technology of Direct Hemoperfusion Aiming to Remove Immunosuppressive Cytokines from the Blood of Cancer-Bearing Hosts

Fundamental Research on the Development of a New Technology of Direct Hemoperfusion Aiming to Remove Immunosuppressive Cytokines from the Blood of Cancer-Bearing Hosts
开发直接血液灌流新技术以去除癌症宿主血液中的免疫抑制细胞因子的基础研究
批准号:
14571152
负责人:
UEDA Yuji
金额:
$1.92万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2003

项目摘要

项目成果

UEDA Yuji的其他基金

相似基金

相关文献

中文摘要
翻译
我们对直接血液灌流新技术的开发进行了基础性研究,目的是去除肿瘤宿主血液中的免疫抑制细胞因子。对聚苯乙烯基复合纤维进行化学改性制备免疫抑制物质吸附(ISA)纤维。简而言之,在多聚甲醛存在的情况下,用n -甲基-α-氯乙酰胺在硫酸和硝基苯的混合物中处理复合纤维。通过填充0.4 g ISA纤维制备容量为2 ml的无菌圆柱形塑料柱。将KDH-8肝癌细胞皮下植入WKAH/Hm大鼠背部,制备荷瘤大鼠。用这些柱直接灌流荷瘤大鼠的血液,可显著降低肿瘤的生长。延长了他们的生存时间。这些柱能有效地去除荷瘤大鼠血液中的TGFb、VEGF和IL-6。
英文摘要
We have done a fundamental research on the development of a new technology of direct hemoperfusion aiming to remove immunosuppressive cytokines from the blood of cancer-bearing hosts. Immunosuppressive substance adsorption (ISA) fiber was prepared by chemical modification of a polystyrene-based composite fiber. In brief, the composite fiber is treated with N-methylol-α-chloroacetamide in a mixture of sulfuric acid and nitrobenzene in the presence of paraformaldehyde. Sterile cylindrical plastic columns with a capacity of 2 ml were prepared by filling 0.4 g of ISA fiber. Tumor-bearing rats were made by implanting KDH-8 cells (hepatocelllar carcinoma) subcutaneously into the back of WKAH/Hm rats. Direct hemoperfusion of tumor-bearing rats using these columns significantly reduced the tumor growth and. prolonged the survival of them. These columns efficiently removed TGFb, VEGF, and IL-6 from the blood of tumor-bearing rats.
期刊论文(12)
专著(0)
科研奖励(0)
会议论文
上田祐二, 他: "新しい癌の体外循環治療技術の開発"医学のあゆみ. 208・12. 1012-1013 (2004)
Yuji Ueda等人:“癌症体外循环治疗新技术的开发”医学史208・1013(2004年)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Yuji Ueda, Yoshiki Yamamoto, Hisakazu Yamagishi, Masaaki Shimagaki, Kazuo Teramoto: "New Technology of Direct Hemoperfusion for Cancer Therapy"Igaku-no-Ayumi (in Japanese). 208(12). 1012-1013 (2004)
Yuji Ueda、Yoshiki Yamamoto、Hisakazu Yamagishi、Masaaki Shimagaki、Kazuo Teramoto:“癌症治疗直接血液灌流新技术”Igaku-no-Ayumi(日语)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Yuji Ueda, et al.: "Dendritic cell-based immunotherapy of cancer with the carcinoembryonic antigen-derived, HLA-A24-restricted CTL epitope."International Journal of Oncology. 24・4. 909-918 (2004)
Yuji Ueda 等人:“使用癌胚抗原衍生的 HLA-A24 限制性 CTL 表位进行基于树突状细胞的癌症免疫疗法”。《国际肿瘤学杂志》24·4(2004 年)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Yuji Ueda, et al.: "Dendritic cell based immunotherapy of cancer with the carcinoembryonic antigen-derived, HLPvA24-restricted CTL epitope."International Journal of Oncology. 24. 909-918 (2004)
Yuji Ueda 等人:“使用癌胚抗原衍生的 HLPvA24 限制性 CTL 表位进行基于树突状细胞的癌症免疫疗法。”国际肿瘤学杂志。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 6 条
    photoreceptor cell sheet derived from mouse iPS cells
    • 批准号:
      24659769
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.41万
    • 财政年份:
      2012
    • 负责人:
      UEDA Yuji
    • 依托单位:
    Development of the Japanese learning to bring up the communications skills in the information and communication media
    • 批准号:
      22530941
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.0万
    • 财政年份:
      2010
    • 负责人:
      UEDA Yuji
    • 依托单位:
    Electric and magnetic properties of nano-structure films produced by computer controlled pulse electrodeposition
    • 批准号:
      14550648
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.28万
    • 财政年份:
      2002
    • 负责人:
      UEDA Yuji
    • 依托单位:
    Development of viral antigen specific immunotherapy for Epstein-Barr virus related gastric cancer.
    • 批准号:
      12671249
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.15万
    • 财政年份:
      2000
    • 负责人:
      UEDA Yuji
    • 依托单位:
    海外基金